Aurisco Pharmaceutical Co.,Ltd.
SSE:605116.SS
21.07 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 769.44 | 545.837 | 391.74 | 444.612 | 564.096 | 265.057 | 180.715 | 212.893 | 183.575 |
| Short Term Investments
| 299.83 | 0 | 0 | 0 | 0 | 0 | 0.3 | 0 | 47.15 |
| Cash and Short Term Investments
| 1,069.27 | 545.837 | 391.74 | 444.612 | 564.096 | 265.057 | 180.715 | 212.893 | 183.575 |
| Net Receivables
| 355.106 | 299.09 | 222.108 | 140.721 | 142.849 | 135.136 | 121.397 | 126.469 | 128.842 |
| Inventory
| 589.722 | 509.8 | 444.939 | 326.798 | 237.792 | 240.204 | 227.936 | 187.971 | 203.675 |
| Other Current Assets
| 32.698 | 11.314 | 29.571 | 27.669 | 33.022 | 24.457 | 23.71 | 18.687 | 65.047 |
| Total Current Assets
| 2,046.796 | 1,366.041 | 1,088.358 | 939.8 | 977.759 | 664.854 | 553.758 | 546.021 | 581.139 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 1,497.188 | 878.328 | 674.184 | 593.262 | 490.352 | 382.73 | 328.226 | 229.192 | 155.973 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 161.458 | 121.396 | 122.712 | 40.419 | 41.939 | 42.699 | 32.71 | 33.258 | 33.829 |
| Goodwill and Intangible Assets
| 161.458 | 121.396 | 122.712 | 40.419 | 41.939 | 42.699 | 32.71 | 33.258 | 33.829 |
| Long Term Investments
| -166.365 | 79.299 | 55.3 | 15.3 | 0.3 | 0.3 | 0 | 0.3 | 0.3 |
| Tax Assets
| 15.785 | 14.295 | 12.783 | 8.56 | 6.302 | 9.665 | 5.703 | 7.611 | 10.508 |
| Other Non-Current Assets
| 322.56 | 115.252 | 79.507 | 124.092 | 16.56 | 0 | 0.3 | 0 | 0.073 |
| Total Non-Current Assets
| 1,830.626 | 1,208.569 | 944.485 | 781.633 | 555.454 | 435.394 | 366.939 | 270.361 | 200.683 |
| Total Assets
| 3,877.422 | 2,574.611 | 2,032.843 | 1,721.433 | 1,533.213 | 1,100.248 | 920.697 | 816.382 | 781.822 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 358.677 | 173.584 | 115.179 | 137.277 | 97.047 | 78.951 | 95.119 | 66.056 | 82.706 |
| Short Term Debt
| 20.017 | 45.184 | 36.226 | 0 | 0 | 0 | 0 | 21 | 48 |
| Tax Payables
| 28.546 | 19.865 | 14.956 | 10.578 | 18.298 | 17.424 | 18.018 | 24.128 | 44.535 |
| Deferred Revenue
| 0 | 22.249 | 0.977 | 50.755 | 1.926 | 0.107 | 0.041 | 41.518 | 58.719 |
| Other Current Liabilities
| 124.797 | 240.142 | 155.81 | 36.263 | 24.338 | 20.156 | 16.395 | 17.881 | 14.203 |
| Total Current Liabilities
| 532.037 | 501.024 | 322.172 | 193.078 | 141.61 | 116.638 | 129.572 | 129.066 | 189.444 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 922.191 | 71.699 | 16.46 | 13.909 | 6.768 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 91.566 | 34.018 | 7.69 | 4.531 | 4.137 | 4.382 | 3.015 | 2.739 | 1.865 |
| Deferred Tax Liabilities Non-Current
| 0.1 | 0.284 | 2.362 | 1.918 | 2.234 | 1.944 | 0.57 | 0.631 | 0.703 |
| Other Non-Current Liabilities
| 0 | 0 | 12.501 | 0 | 4.137 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 1,013.857 | 106.001 | 26.512 | 20.359 | 6.37 | 6.327 | 3.584 | 3.37 | 2.568 |
| Total Liabilities
| 1,545.894 | 607.025 | 348.684 | 213.437 | 147.98 | 122.965 | 133.156 | 132.436 | 192.013 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.501 |
| Common Stock
| 406.195 | 406.195 | 406.195 | 401 | 401 | 360 | 360 | 360 | 52.8 |
| Retained Earnings
| 1,122.811 | 881.699 | 680.063 | 537.88 | 429.05 | 321.473 | 147.812 | 59.756 | 362.098 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 105.231 | 77.493 | 65.308 | 78.397 | 279.729 | 264.191 | -2.501 |
| Other Total Stockholders Equity
| 802.523 | 679.691 | 589.924 | 567.367 | 489.874 | 217.413 | 263.784 | 251.01 | 65.632 |
| Total Shareholders Equity
| 2,331.529 | 1,967.585 | 1,676.168 | 1,506.247 | 1,385.232 | 977.283 | 787.541 | 683.947 | 552.082 |
| Total Equity
| 2,331.529 | 1,967.585 | 1,684.159 | 1,507.996 | 1,385.232 | 977.283 | 787.541 | 683.947 | 589.809 |
| Total Liabilities & Shareholders Equity
| 3,877.422 | 2,574.611 | 2,032.843 | 1,721.433 | 1,533.213 | 1,100.248 | 920.697 | 816.382 | 781.822 |